In this article, we will discuss the 5 Best Insurance Stocks to Buy Following Q1 Earnings. For deeper discussion and analysis, read 10 Best Insurance Stocks to Buy Following Q1 Earnings.
5. Fidelity National Financial, Inc. (NYSE:FNF)
Target Price: $46.47
Upside Potential: 33.85%
On May 12, Stephens lowered its price target on Fidelity National Financial, Inc. (NYSE:FNF) to $58 from $61 while maintaining an Overweight rating on the shares. The firm noted that Fidelity delivered solid first-quarter results, demonstrating resilience despite ongoing challenges in the housing and mortgage markets. However, Stephens adjusted its near-term outlook to account for increased uncertainty surrounding interest rate expectations and a slower-than-anticipated recovery in residential real estate activity.
On May 11, Barclays analyst Terry Ma reduced the firm’s price target on Fidelity National Financial, Inc. (NYSE:FNF) to $50 from $54 while maintaining an Equal Weight rating on the stock. The revised target reflects a more cautious outlook for the operating environment as market participants continue to assess the impact of interest rates and housing market conditions on transaction volumes and industry activity.
Incorporated in 1984, Fidelity National Financial, Inc. (NYSE:FNF) is headquartered in Jacksonville, Florida. As the nation’s largest title insurance company, it primarily provides title insurance, escrow, and settlement services to the real estate and mortgage industries, while also offering select annuity and life insurance products.
4. Ryan Specialty Holdings, Inc. (NYSE:RYAN)
Target Price: $41.89
Upside Potential: 35.74%
Ryan Specialty Holdings, Inc. (NYSE:RYAN) attracted mixed but noteworthy analyst attention on June 8 when Goldman Sachs downgraded the stock to Neutral from Buy and lowered its price target to $35 from $42. The firm cited expectations for a prolonged period of commercial property and casualty insurance pricing moderation, which could make it more difficult for the company to achieve consensus forecasts for accelerating organic growth in future years. Despite the downgrade, Goldman acknowledged that Ryan Specialty remains a leading participant in the specialty insurance market, with concerns centered primarily on growth expectations rather than the quality of the underlying business.
Previously, on May 27, Keefe Bruyette raised its price target on Ryan Specialty Holdings, Inc. (NYSE:RYAN) to $44 from $42 while maintaining an Outperform rating. The firm viewed the company’s decision to increase its share repurchase authorization by $300 million as a strong signal of management’s confidence in its financial position, cash-generation capabilities, and long-term growth prospects. The expanded buyback program highlights Ryan Specialty’s ability to return capital to shareholders while continuing to invest in its business and strategic growth initiatives.
Founded in 2010 and headquartered in Chicago, Illinois, Ryan Specialty Holdings, Inc. (NYSE:RYAN) is an international specialty insurance organization that operates as a wholesale broker and managing underwriter. The company provides specialized distribution, underwriting, product development, and risk-management services for complex or difficult-to-place insurance risks.
3. James River Group Holdings, Inc. (NASDAQ:JRVR)
Target Price: $5.38
Upside Potential: 35.86%
On May 19, UBS downgraded James River Group Holdings, Inc. (NASDAQ:JRVR) to Neutral from Buy and reduced its price target to $4.75 from $8.00. The firm cited a higher cost of equity capital stemming from increased risks related to adverse reserve development. UBS also noted that intensifying competition within the small- to middle-market excess and surplus lines sector could make it more difficult for the company to achieve meaningful growth, leading the analyst to adopt a more cautious stance on the shares.
Previously, on May 5, Citizens downgraded James River Group Holdings, Inc. (NASDAQ:JRVR) to Market Perform from Outperform without assigning a price target. The firm pointed to disappointing first-quarter results and highlighted that the company utilized approximately two-thirds of its remaining excess and surplus adverse development cover limit, leaving only $7.5 million available for potential future adverse development. According to the analyst, the reduced protection weakens a key risk-mitigation mechanism that had previously provided investors with greater confidence regarding reserve-related exposures.
Founded in 2002 and headquartered in Pembroke, Bermuda, James River Group Holdings, Inc. (NASDAQ:JRVR) is an insurance holding company that owns and operates a group of specialty property-casualty insurance and reinsurance companies, operating primarily in the U.S. excess and surplus (E&S) lines market.
2. Abacus Global Management, Inc. (NYSE:ABX)
Target Price: $13.64
Upside Potential: 64.14%
On May 27, Abacus Global Management, Inc. (NYSE:ABX) and Manning & Napier announced the formation of a strategic alliance agreement alongside the completion of Abacus’s minority equity investment in Manning & Napier. Through the transaction, Abacus joins Callodine Group and East Asset Management as an institutional investor in the firm. The partnership is intended to create value across several key areas, including lead generation and referral opportunities, product development and distribution initiatives, and the delivery of integrated client solutions. The agreement establishes a framework for ongoing collaboration between the two organizations and is expected to enhance the capabilities and reach of their respective platforms.
On May 8, Piper Sandler analyst Crispin Love raised the firm’s price target on Abacus Global Management, Inc. (NYSE:ABX) to $10 from $9.50 while maintaining a Neutral rating on the shares. The firm noted that the company delivered core results that exceeded its internal expectations, although performance came in slightly below broader market estimates. Importantly, Abacus increased its 2026 guidance, raising the midpoint of its adjusted net income forecast to $103 million from the previous midpoint of $100 million, reflecting management’s confidence in the company’s earnings trajectory and business momentum.
Founded in 2004 and headquartered in Orlando, Florida, Abacus Global Management, Inc. (NYSE:ABX) is a financial services firm that specializes in alternative asset management, data-driven wealth solutions, life settlements, and life insurance-related technology innovations.
1. Exzeo Group, Inc. (NYSE:XZO)
Target Price: $26
Upside Potential: 94.18%
On May 26, Exzeo Group, Inc. (NYSE:XZO) announced that its Board of Directors authorized a new share repurchase program and adopted a corresponding Rule 10b5-1 trading plan to acquire up to $12 million of the company’s common stock, subject to market conditions. The authorization became effective immediately and reflects management’s confidence in the company’s long-term prospects, while providing an additional mechanism to return value to shareholders and potentially enhance earnings per share over time.
On May 6, Exzeo Group, Inc. (NYSE:XZO) reported first-quarter revenue of $55.53 million compared with consensus expectations of $58.06 million. Despite the revenue shortfall, management highlighted continued momentum across the Exzeo platform, including strong growth in managed premiums and the addition of a seventh insurance carrier partner. Chairman and Chief Executive Officer Paresh Patel stated that the company has successfully executed on several strategic priorities since its initial public offering, including driving profitable growth with existing carrier partners, expanding relationships with third-party clients, and advancing product innovation throughout its platform. The company’s progress underscores its focus on scaling operations and strengthening its position within the insurtech market.
Founded in 2012 and headquartered in Tampa, Florida, Exzeo Group, Inc. (NYSE:XZO) is an insurtech company that provides software and analytics tools. It develops an Insurance-as-a-Service (IaaS) platform that helps property and casualty insurers manage operations such as quoting, underwriting, claims processing, and policy management.
While we acknowledge the potential of XZO as an insurance stock, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than XZO and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 7 Best 3D Printing Stocks to Buy for Aerospace Components and Top 10 Stocks That Members of Congress Own.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
